![Diane J. Kalina](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Diane J. Kalina
Presidente presso BioCatalyst Yorkton, Inc.
Posizioni attive di Diane J. Kalina
Società | Posizione | Inizio | Fine |
---|---|---|---|
BioCatalyst Yorkton, Inc. | Direttore/Membro del Consiglio | 17/01/2011 | - |
Presidente | 01/01/2005 | - |
Storia della carriera di Diane J. Kalina
Precedenti posizioni note di Diane J. Kalina
Società | Posizione | Inizio | Fine |
---|---|---|---|
Arius Research, Inc.
![]() Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada. | Direttore/Membro del Consiglio | 01/04/2003 | 06/12/2007 |
YM BioSciences, Inc.
![]() YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Direttore/Membro del Consiglio | - | - |
Presidente | - | - | |
GSK Products, Inc.
![]() GSK Products, Inc. Wholesale DistributorsDistribution Services Part of Princeton American Corp., GSK Products, Inc. is a beauty and barber supply concern. The company is based in Phoenix, AZ. | Vendite & Marketing | - | - |
PDC Biotech GmbH
![]() PDC Biotech GmbH BiotechnologyHealth Technology PDC Biotech GmbH operates as a biopharmaceutical company developing innovative therapeutics for the treatment of preterm labor and primary dysmenorrheal in women. The firm’s pipeline products include prostaglandin F2a (FP) receptor antagonists, PDC31 a synthetic octapeptide, which is designed to act as an allosteric modulator of the receptor for prostaglandin FP receptor. The company was founded by Patricia Griffin and Diane J. Kalina in May 2008 and is headquartered in Vienna, Austria. | Amministratore Delegato | 01/05/2008 | - |
Fondatore | 01/05/2008 | - | |
E3 LITHIUM LIMITED | Direttore Finanziario/CFO | - | - |
Statistiche
Distribuzione geografica
Canada | 5 |
Austria | 2 |
Stati Uniti | 2 |
Posizioni
Director/Board Member | 3 |
President | 2 |
Director of Finance/CFO | 1 |
Settori
Health Technology | 4 |
Process Industries | 2 |
Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
E3 LITHIUM LIMITED | Process Industries |
Aziende private | 5 |
---|---|
Arius Research, Inc.
![]() Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada. | Health Technology |
BioCatalyst Yorkton, Inc. | |
PDC Biotech GmbH
![]() PDC Biotech GmbH BiotechnologyHealth Technology PDC Biotech GmbH operates as a biopharmaceutical company developing innovative therapeutics for the treatment of preterm labor and primary dysmenorrheal in women. The firm’s pipeline products include prostaglandin F2a (FP) receptor antagonists, PDC31 a synthetic octapeptide, which is designed to act as an allosteric modulator of the receptor for prostaglandin FP receptor. The company was founded by Patricia Griffin and Diane J. Kalina in May 2008 and is headquartered in Vienna, Austria. | Health Technology |
GSK Products, Inc.
![]() GSK Products, Inc. Wholesale DistributorsDistribution Services Part of Princeton American Corp., GSK Products, Inc. is a beauty and barber supply concern. The company is based in Phoenix, AZ. | Distribution Services |
YM BioSciences, Inc.
![]() YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
- Borsa valori
- Insiders
- Diane J. Kalina
- Esperienza